This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Eli Lilly & Co. plunged 11.7% to $794.10 on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.6% to 5,604.14 and the Dow Jones Industrial Average rising 0.2% to 40,752.96.
The stock's fall snapped a two-day winning streak.
Eli Lilly & Co. closed 18.3% below its 52-week high of $972.53, which the company achieved on August 22nd.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson fell 1.2% to $154.46, Pfizer Inc. fell 2.0% to $23.93, and AbbVie Inc. fell 0.90% to $193.34.
Trading volume totaled 12.5 million, compared to the 50-day average of 3.7 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 01, 2025 16:33 ET (20:33 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。